Wulf Siggelkow

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Histological analysis of silicone breast implant capsules and correlation with capsular contracture

Wulf Siggelkow, A. Faridi, Katrin Spiritus et al. · Biomaterials · 2002 · 222 citations

Histological Analysis, Surgery, Biomedical Engineering +3

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian Cancer

Michael Zimny, Wulf Siggelkow, W. Schröder et al. · Gynecologic Oncology · 2001 · 145 citations

Positron Emission Tomography, Radiology, Oncologic Imaging +10

Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach

Daniel Böhm, Ksenia Keller, Julia Pieter et al. · Oncology Reports · 2012 · 102 citations · Full text

Breast Oncology, Engineering, Pathology +17

Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients

Wulf Siggelkow, Daniel Boehm, Susanne Gebhard et al. · BMC Cancer · 2012 · 95 citations · Full text